Home » Posts tagged 'feedback' (Page 4)
Tag Archives: feedback
Feedback (FDBK) – Exercise of Options
Feedback plc (FDBK), the medical imaging software company, has received notification of an exercise of options over 1.6 million new ordinary shares by an employee under its EMI share option scheme. The exercise price of the options is 1.25 pence each.
The New Ordinary Shares will rank pari passu with the existing ordinary shares and application will be made for the New Ordinary Shares to be admitted to trading on AIM. It is expected that Admission will become effective and dealings in the New Ordinary Shares will commence by 8.00 a.m. on 15 July 2015.
Following Admission the Company will have a total issued share capital of 203,673,857 ordinary shares with voting rights. This number may be used by shareholders as the denominator for the calculations by which they will determine if they are required to notify their interest in, or a change to their interest in, the share capital of the Company under the Financial Conduct Authority’s Disclosure and Transparency Rules.
For further information contact:
|
Feedback plc |
Tel: 01954 718072 |
|
Simon Barrell / Trevor Brown / Tom Charlton |
|
|
|
|
|
Sanlam Securities UK (Nominated Adviser and Joint Broker) |
Tel: 020 7628 2200 |
|
Simon Clements / Virginia Bull |
|
|
|
|
|
Peterhouse Corporate Finance Ltd (Joint Broker) |
Tel: 020 7469 0936 |
|
Lucy Williams / Duncan Vasey |
Feedback PLC – Issue of equity
Feedback plc (FDBK), the medical imaging software company, announces that it has issued and allotted 216,000 new ordinary shares of 0.25 pence each at a price of 1.25 pence per ordinary share to Brand UK Limited, the Company’s PR adviser, in lieu of fees for professional services provided to the Company.
The New Ordinary Shares will rank pari passu with the existing ordinary shares and application will be made for the New Ordinary Shares to be admitted to trading on AIM. It is expected that Admission will become effective and dealings in the New Ordinary Shares will commence by 8.00 a.m. on 10 July 2015.
Following Admission of the Placing Shares, the Company’s enlarged issued share capital will consist of 202,073,857 ordinary shares with voting rights. This number may be used by shareholders, following the Placing, as the denominator for the calculations by which they will determine if they are required to notify their interest in, or a change to their interest in, the share capital of the Company under the Financial Conduct Authority’s Disclosure and Transparency Rules.
For further information contact:
|
Feedback plc |
Tel: 01954 718072 |
|
Simon Barrell / Trevor Brown / Tom Charlton |
|
|
Sanlam Securities UK (Nominated Adviser and Joint Broker) |
Tel: 020 7628 2200 |
|
Simon Clements / Virginia Bull |
|
|
Peterhouse Corporate Finance Ltd (Joint Broker) |
Tel: 020 7469 0936 |
|
Lucy Williams / Duncan Vasey |
|
See Brand Communications disclosure statement here
Feedback PLC – Dr Balaji Ganeshan interviewed by Justin Waite on the ADVFN podcast
Feedback PLC – Chief Scientist & News Business Officer Dr Balaji Ganeshan is interviewed by Justin Waite on the ADVFN podcast.
The interview can be found 20 minutes & 30 seconds into the podcast, click here to listen to the podcast.
Feedback PLC – Dr Balaji Ganeshan talking at UK Radiological Congress 2015
Dr. Balaji Ganeshan, Chief Scientist & New Business Officer at Feedback PLC, (and group companies TexRAD and CCI Ltd) will be giving a talk entitled “Quantifying Tumour heterogeneity with TexRAD texture analysis on CT and MRI”
Where: at the Guerbet Laboratories Ltd stand at UK Radiological Congress 2015 in Liverpool, UK (30th June 4pm and 1st July 11am).
Full details of the conference can be found on the UKRC website here.
Attendees and delegates please register at the Guerbet stand.
Feedback (FDBK) – Total voting rights
Feedback plc announces in accordance with the FCA’s Disclosure and Transparency Rules that the issued share capital of the Company comprises 201,857,857 ordinary shares.
Shareholders should use 201,857,857 as the denominator for the calculations by which they can determine if they are required to notify their interest in, or a change to their interest in, the Company under the Rules.
For further information contact:
|
Feedback plc |
Tel: 01954 718072 |
|
Simon Barrell / Trevor Brown / Tom Charlton |
|
|
Sanlam Securities UK (Nominated Adviser and Joint Broker) |
Tel: 020 7628 2200 |
|
Simon Clements / Virginia Bull |
|
|
Peterhouse Corporate Finance Ltd (Joint Broker) |
Tel: 020 7469 0936 |
|
Lucy Williams / Duncan Vasey |
|
ShareProphets – Feedback Shares Soften, but is that a Buying Opportunity?
By Malcom Stacey at ShareProphets
Hello Share Sappers. I beg your indulgence to return to Feedback (FDBK), the company which uses whizzo computers to help diagnose and monitor many types of cancer. As reported previously, this could be a topping investment. Though, as per usual, we should always add a cautionary note about medical pioneers.
This is because they can always be taken over by some even more revolutionary gizmo or they might not get every licence they hope for.
There is also the worry that the NHS, to name just one medical services giant, is short of money these days as the number of patients grow, fuelled by longevity.
Having said that, I want to go over a few reasons why I’m so enthusiastic about Feedback.
One, it is a small company, capitalised at just £5million and has a comparatively small number of shares out there.
A heck of a lot of these shares are owned by directors, families and friends.
This means there are even fewer shares in the market place. And we all know the effects of limited supply and demand.
Also the very fact that the big cheeses of Feedback have so much skin in the game is very re-assuring.
As usual with this sort of pioneering company, a bit of good news – like a tasty new contract – will send the shares skywards. And, after a fallow time, good news could be about due.
The shares reached a high not so long ago at 3.2 pence. It’s softened to 2.8p since then, as profit takers have succumbed to temptation. But nothing has happened to justify the slight fall, and if you read the company’s bumph and believe it, there should be some jolly profit to come.
Click here for full ShareProphets article.
Feedback company TexRAD wins the inaugural Sussex Impact Award at the University of Sussex
Sussex research has improved lives and changed the outside world in areas from lad culture to chemical weapons and sustainable food, as recognised by an inaugural awards ceremony on campus on16 June.
The winners of the first Sussex Impact and Research Awards were announced at a celebratory reception in the Jubilee building.
Sussex researchers from across the University joined the Vice-Chancellor and external guests for Tuesday evening’s event, which followed the first Sussex Impact Day.
Feedback company TexRAD won the inaugural Sussex Impact Award at the University 
of Sussex. There were 3 categories for the awards:
1. Enabling impact for early stage technologies
2. Achieving impact for technologies having an impact
3. Emerging researcher
TexRAD won in the “achieving impact category” – application was put by the Engineers led by Prof. Chris Chatwin with some inputs from Feedback’s Chief Scientist & New Business Officer Dr Balaji Ganeshan.
Link here to read the Sussex Impact and Research Awards article.
Feedback PLC announces the first server sale of TexRAD in Canada
Feedback plc (FDBK), the medical imaging software company, is pleased to announce its first server sale for research purposes in Canada of the Group’s TexRAD texture analysis software. The software will be installed in the Department of Diagnostic Radiology at the McGill University Health Centre’s Montreal General Hospital site.
The MUHC is one of the leading academic health centres in North America. It was founded in 1997 through the merger of five hospitals including the Montreal General Hospital which was established in 1819 and was one of the world’s first teaching hospitals.
Professor Benoit Gallix, Chairman, Department of Diagnostic Radiology (McGill University Director, MUHC) commented, “We are very excited with the prospect of evaluating the TexRAD imaging research software platform at our institution as a potential imaging risk-stratification tool. TexRAD will form part of a research study of breast cancer patients who have had digital mammography imaging examinations. The MUHC database has approximately 20,000 digital mammograms with clinical follow-up acquired over a period of 15 to 20 years. This comprehensive research study could help to provide an evidence base for the potential application of TexRAD in breast cancer patient management”
Dr. Balaji Ganeshan, Chief Scientist and New Business Officer at the Group’s subsidiaries TexRAD Ltd and Cambridge Computed Imaging Ltd, commented, “We are delighted to receive this first server order in Canada, particularly from the very prestigious MUHC, Montreal, Quebec and we are honoured to be working with Professor Benoit Gallix and his team. Breast cancer is the most common cancer in the UK with around 55,000 people (predominantly women) diagnosed with the disease every year. Research and development into non-invasive imaging based risk-stratification tools such as TexRAD research software could potentially lead to TexRAD’s use as a supplementary tool in digital mammography to achieve better patient management and improved overall outcomes in the future.”
For further information contact:
|
Feedback plc |
Tel: 01954 718072 |
|
Simon Barrell / Trevor Brown / Tom Charlton |
|
|
Sanlam Securities UK (Nominated Adviser and Joint Broker) |
|
|
Simon Clements / Virginia Bull |
Tel: 020 7628 2200 |
|
Peterhouse Corporate Finance Ltd (Joint Broker) |
Tel: 020 7469 0936 |
|
Lucy Williams / Duncan Vasey |
|
Feedback PLC – Statement re Share Price Movement
The Board of Feedback plc (FDBK), the medical imaging software company, notes the increase in the Company’s share price, trading volume and speculation on bulletin boards.
As announced on the 3 June 2015, the Company completed a successful placing with Director participation which has attracted positive media comment however the Board can confirm they know of no other reason that would lead to such a movement in the Company’s share price and the increase in trading volumes.
For further information contact:
|
Feedback plc |
Tel: 01954 718072 |
|
Simon Barrell / Trevor Brown / Tom Charlton |
|
|
Sanlam Securities UK (Nominated Adviser and Joint Broker) |
|
|
Simon Clements / Virginia Bull |
Tel: 020 7628 2200 |
|
Peterhouse Corporate Finance Ltd (Joint Broker) |
Tel: 020 7469 0936 |
|
Lucy Williams / Duncan Vasey |
|
Feedback (FDBK) raises £200,000 to fund TexRAD development
Feedback plc (FDBK), the medical imaging software company, is pleased to announce that it has placed 11,111,111 new ordinary shares of 0.25 pence each at a price of 1.8 pence per ordinary share with a number of existing and new investors raising £200,000. The Placing has been completed by Peterhouse Corporate Finance Limited.
The proceeds of the Placing will fund continuing development of the TexRAD software.
The Placing includes participation by two of Feedback’s directors, Tom Charlton who invested £50,400 for 2,800,000 Placing Shares and Trevor Brown who invested £18,000 for 1,000,000 Placing Shares both at a price of 1.8 pence per ordinary share. Following the Placing, the Participating Directors will be interested in a total of 104,613,919 ordinary shares in the Company representing 51.83% of the enlarged issued share capital of the Company. The shareholdings of the Participating Directors on completion of the Placing will be as follows:
| Director | No. of Shares | % |
| Trevor Brown | 55,089,111 | 27.29 |
| Tom Charlton | 49,524,808 | 24.53 |
The Placing Shares will rank pari passu with the existing Ordinary Shares and application will be made for the Placing Shares to be admitted to trading on AIM. It is expected that Admission will become effective and dealings in the Placing Shares will commence by 8.00 a.m. on 8 June 2015.
Following Admission of the Placing Shares, the Company’s enlarged issued share capital will consist of 201,857,857 ordinary shares with voting rights. This number may be used by shareholders, following the Placing, as the denominator for the calculations by which they will determine if they are required to notify their interest in, or a change to their interest in, the share capital of the Company under the Financial Conduct Authority’s Disclosure and Transparency Rules.
Related Party Transaction:
Due to the fact that Trevor Brown and Tom Charlton are directors of the Company and the size of their respective shareholdings, their participation in the Placing constitutes a related party transaction as defined in the AIM Rules. Simon Barrell, Non-Executive Chairman, has not participated in the Placing and is therefore deemed to be independent under the AIM Rules for the purposes of considering the related party transaction. The Independent Director, having consulted with Sanlam Securities UK Limited, the Company’s nominated adviser, considers that the terms of the participation in the Placing by the Participating Directors are fair and reasonable insofar as the Company’s shareholders are concerned.
For further information please contact:
| Feedback plc | Tel: 01954 718072 |
| Simon Barrell / Trevor Brown / Tom Charlton
|
|
| Sanlam Securities UK (Nominated Adviser and Joint Broker) | Tel: 020 7628 2200 |
| Simon Clements / Virginia Bull/ Andrew Wagstaff
|
|
| Peterhouse Corporate Finance Ltd (Joint Broker) | Tel: 020 7469 0936 |
| Lucy Williams / Duncan Vasey |